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Healthcare-associated infections, also known as nosocomial 
infections, which affect patients in a hospital or healthcare facility 
and were not present or incubating at the time of admission,[1] are 
among the main patient safety challenges in healthcare facilities. [2] 
They can be defined as an infection that develops 48 hours after 
hospital admission or within 48 hours after discharge.[3] In spite of 
improvements in healthcare, nosocomial infections continue and 
can be acquired anywhere healthcare is delivered, including inpatient 
acute-care hospitals, outpatient settings such as ambulatory surgical 
centres, end-stage renal disease facilities, and long-term care facilities 
such as nursing homes and rehabilitation centres. The development 
of nosocomial infections is dependent on two key pathophysiological 
factors: decreased host defences and colonisation by pathogenic or 
potentially pathogenic organisms.[4] A survey published by the New 
England Journal of Medicine (cited in Becker’s Clinical Leadership 
and Infection Control[5]) provides important insight for healthcare 
providers in their efforts to combat infections, reporting prevalence 
of the five commonest recorded nosocomial infections as follows: 
pneumonia 21.8% of all healthcare-associated infections; surgical 
site infection (SSI) 21.8%; gastrointestinal infection 17.1%; urinary 
tract infection 12.9%; and primary bloodstream infection 9.9%. It is 
estimated that ~1 in 7 patients entering South African (SA) hospitals 
is at high risk of acquiring a nosocomial infection.[6] Neurosurgical 
patients are particularly vulnerable because of the serious nature 
of their illnesses, the frequency of associated trauma, and the 
presence of invasive devices. Neurosurgeons treat conditions such as 
aneurysms, stroke, epilepsy, meningitis, traumatic brain injury, spinal 
cord injury and brain tumours, all of which predispose patients to 
fungal, viral and bacterial infections. A study conducted in Pretoria, 
SA, reported that the incidence of ventriculitis reached 28.3% among 
paediatric neurosurgical patients.[7]
Objectives
Nelson Mandela Academic Hospital (NMAH) in Mthatha, like many 
hospitals in SA,[7] faces high rates of nosocomial infections. The 
present study sought to determine the aetiology and incidence of 
these infections following neurosurgical procedures, as well as the 
associated risk factors.
Methods
This was a descriptive cross-sectional study. Patients were enrolled 
from 1 October 2013 to 30 September 2014. All inpatients who 
had had a neurosurgical procedure at NMAH during the study 
period were included in the study if their medical and laboratory 
records were accurate, legible and complete. Medical records were 
accessed in the Department of Neurosurgery at NMAH where 
patients were admitted, while laboratory records were obtained from 
the Department of Medical Microbiology at the National Health 
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Laboratory Service (NHLS), NMAH. Accuracy of records was 
assessed in terms of precision of information or instructions related 
to the patient and his/her condition. Legibility of records was assessed 
in terms of clarity and readability, while completeness of records was 
assessed in terms of completeness of information or instructions 
provided in the records.
Clinical samples (blood, pus, pus swabs, cerebrospinal fluid 
(CSF), catheter tips, wound aspirates and tissues) were collected 
by medical doctors in the neurosurgical unit as part of routine 
patient management and submitted to the Department of Medical 
Microbiology at the NHLS for analysis.
The isolates were then stored in skim-milk agar and kept at –20ºC 
until further use (for identification and antimicrobial susceptibility 
testing). They were then subcultured into nutrient agar and 
McConkey agar and incubated for 24 hours at 37oC.
The API-20E test kit (bioMérieux, USA) was used for identification 
of members of the family Enterobacteriaceae and associated non-
fastidious organisms. The oxidase test was used to identify bacteria 
that produce cytochrome C oxidase, an enzyme of the bacterial 
electron transport chain. The test is used in differentiating between 
the Enterobacteriaceae and pseudomonads, which are oxidase-
negative and oxidase-positive, respectively. An analytical profile 
index for species identification (RAPIDEC STAPH, bioMérieux, 
USA) was used to identify staphylococci and micrococci, and a salt 
tolerance test was used to identify enterococcal group D streptococci 
on the basis of their salt tolerance.
MicroScan (WalkAway 96 IS system; Siemens, UK) panels were 
used for further identification of micro-organisms, as follows: 
modified conventional and chromogenic tests were used to 
identify fermentative and non-fermentative Gram-negative bacilli. 
Identification was based on detection of pH changes, substrate 
utilisation, and growth in the presence of antimicrobial agents after 
16 - 42 hours’ incubation at 35oC.
In this study, we measured the incidence proportion, defined as 
the measure of the risk of developing a new neurosurgical infection 
within a 12-month period. To calculate the incidence proportion, the 
numerator was the number of disease onsets (all new cases of post-
surgical infection) and the denominator was the number of patients 
initially at risk (all patients who underwent a neurosurgical procedure).
To determine risk factors associated with neurosurgical infections, 
clinical information was collected from patients, including demographic 
characteristics and clinical status (such as underlying diseases). Data 
on microbial treatment of micro-organisms were recorded, including 
antibiotic, dose administered, routes of administration, duration of 
therapy, and dates of admission, surgery and discharge.
Wound class, neurosurgical procedure, antibiotic use, infecting 
pathogens, severity of illness and preoperative time were recorded. 
In the event of infection, detailed records were collected regarding 
treatment provided and patient outcome, as well as the type of 
invasive device used during neurosurgery.
Statistical analysis
Continuous variables were expressed as means and standard error 
of the mean (SEM), and categorical variables were expressed as 
proportions. The level of significance was set at p<0.05. Chi-square 
analysis was performed to determine risk factors associated with 
neurosurgical infections. The Statistical Package for the Social 
Sciences (SPSS), version 23 (IBM, USA), was used for analysis.
Ethical considerations
Ethical clearance was obtained from the Walter Sisulu University 
Ethics and Biosafety Committee (ref. no. 071/2014). Since this study 
included a descriptive survey of clinical and laboratory records, 
permission to access those records was obtained from the hospital 
management at NMAH and also from the NHLS laboratory manager.
Results
Between 1 October 2013 and 30 September 2014, 1 688 patients were 
admitted for neurosurgical procedures at NMAH. Of these patients, 
1 266 (75.0%) were male and 422 (25.0%) were female. The mean 
(SEM) age of the male patients was 17.2 (2.6) years and that of the 
female patients 17.5 (6.4) years.
Of the patients, 127 (7.5%) were clinically suspected to have 
developed a nosocomial infection, but only 71 cases were confirmed 
microbiologically (71/1 688, 4.2%). Of the 127 patients with suspected 
infection, 88 (69.3%) were male and 39 (30.7%) were female. The 
mean (SEM) age of adult patients was 22.8 (2.0) years, while infants 
and neonates had mean ages of 8.14 (1.4) months and 37 (16) days, 
respectively (Table 1).
Of the 127 clinically suspected post-surgical infections, 61 occurred 
after craniotomy and 66 after a ventricular shunt. The commonest 
underlying neurosurgical abnormalities were hydrocephalus (48.8%), 
traumatic brain injury (33.1%) and brain abscess (9.4%), as shown 
in Table 1.
Of 127 clinically suspected cases of nosocomial infection, 61 
(48.0%) and 10 (7.9%) were microbiologically confirmed as SSIs 
and central nervous system infections (CNSIs), respectively. CNSIs 
included meningitis and ventriculoperitoneal (VP) shunt infection.
The results showed that craniotomy was significantly associated 
with SSI rather than CNSI; on the other hand, the presence of 
VP shunt was significantly associated with CNSI rather than SSI 
(p=0.001). When we compared patients with and without confirmed 
nosocomial infections (n=71 and n=56, respectively), traumatic 
Table l. Baseline characteristics of patients diagnosed with 
nosocomial infections based on clinical suspicion during the 
study period (N=127)
Age, mean (SEM)
Adults (years) (n=97) 22.8 (2.0)
Infants (months) (n=28) 8.1 (1.4)
Neonates (days) (n=2) 37 (16)
Gender, n (%)
Male 88 (69.3)
Female 39 (30.7)
Neurosurgical abnormality, n (%)
Intracranial haemorrhage 3 (2.4)
Traumatic brain injury 42 (33.1)
Hydrocephalus 62 (48.8)
Brain abscess 12 (9.4)
Brain tumour 4 (3.1)
Subdural empyema 3 (2.4)
Lumbar spine injury 1 (0.8)
Surgical characteristics, n (%)
Craniotomy 61 (48.0)
Ventriculoperitoneal shunt 65 (51.2)
Spinal cord operation 1 (0.8)
Nosocomial infections, n (%)
Surgical site infection 61 (48.0)
Meningitis 1 (0.8)
Cerebrospinal shunt infection 9 (7.1)
No microbial confirmation 56 (44.1)
SEM = standard error of the mean.
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brain injury and brain abscess were significantly associated with 
the presence of post-surgical infection, while hydrocephalus was 
significantly associated with absence of post-surgical infection 
(p<0.0001). Post-surgical infections were significantly associated 
with craniotomy (p<0.0001), prolonged stay in hospital (>30 days) 
(p=0.008) and patient age ≥35 years (p=0.05) (Table 2).
Length of hospital stay >30 days was significantly associated with 
post-surgical infection (p=0.025), as shown in Fig. 1. To determine 
length of stay as a risk factor in our study, we divided the numbers 
of days spent in the ward into three categories: <14 days, 14 - 30 
days and >30 days. As shown in Fig. 1, the longer a patient spent in 
hospital, the higher the risk became of developing SSI or CNSI.
The associations between post-surgical nosocomial infection 
and the duration of urinary, endotracheal and intravenous catheter 
placement did not reach statistical significance (data not shown).
The commonest aetiological agents isolated from the 71 culture-
positive patients were Staphylococcus aureus (n=14; 19.7%) and 
Klebsiella pneumoniae (n=9; 12.7%) (Table 3). The most frequently 
isolated Gram-positive bacteria were S. aureus (19.7%), Enterococcus 
faecalis (11.3%) and S. epidermidis (9.9%), while the most frequently 
isolated Gram-negative bacteria were K. pneumoniae (12.7%), 
Acinetobacter baumannii (8.5%), Escherichia coli (8.5%) and Proteus 
mirabilis (8.5%) (Table 3).
Of 14 isolates of S. aureus, 6 (42.9%) were methicillin-resistant 
S. aureus (MRSA); however, all were susceptible to vancomycin. The 
remaining 8 non-MRSA isolates (57.1%) were also susceptible to 
erythromycin and clindamycin, but all S. aureus isolates were resistant 
to benzylpenicillin and ampicillin. All 7 isolates of S. epidermidis 
were resistant to benzylpenicillin, ampicillin, erythromycin and 
clindamycin, while 4 (57.1%) were resistant to methicillin. Of the 
8 isolates of E. faecalis, 3 (37.5%) were vancomycin resistant and also 
displayed high-level gentamicin resistance. The remaining isolates 
were all susceptible to ampicillin and benzylpenicillin. All isolates of 
streptococci (either S. milleri or Streptococcus spp.) were susceptible 
to benzylpenicillin, ampicillin, erythromycin, clindamycin and 
vancomycin.
All the Gram-negative isolates considered resistant were extended-
spectrum beta-lactamase (ESBL) producers, and all were resistant 
to third-generation cephalosporins (ceftriaxone, cefotaxime and 
ceftazidime) and gentamicin, but all these ESBL isolates were 
susceptible to carbapenems (imipenem, meropenem and ertapenem), 
piperacillin-tazobactam and amikacin. All ESBL-producing 
K.  pneumoniae and Enterobacter cloacae were also resistant to 
cipro floxacin. As shown in Table 3, 4/9 K. pneumoniae (44.4%), 4/6 
A.  baumannii (66.7%), 2/6 E. coli (33.3%) and P. mirabilis (33.3%), 
and 2/3 E. cloacae (66.7%) were ESBL producers. All isolates 
Table 2. Risk factors associated with nosocomial infections among neurosurgical patients (N=127)
Variables of interest Presence of infection (N=71), n (%) Absence of infection (N=56), n (%) p-value
Gender 0.30
Male 51 (58.0) 37 (42.0)
Female 20 (51.3) 19 (48.7)
Age (years) 0.05
<35 53 (52.0) 49 (48.0)
≥35 18 (72.0) 7 (28.0)
Surgical procedure <0.0001
Craniotomy 57 (93.4) 4 (6.6)
VP shunt 14 (21.2) 52 (78.8)
Length of stay (days) 0.008
<14 10 (35.7) 18 (64.3)
14 - 30 17 (48.6) 18 (51.4)
>30 44 (68.8) 20 (31.2)
Primary diagnosis <0.0001
Traumatic brain injury 41 (97.6) 1 (2.4)
Hydrocephalus 13 (21.0) 49 (79.0)
Brain abscess 9 (75.0) 3 (25.0)
Brain tumour 2 (50.0) 2 (50.0)
Lumbar spine injury 1 (100) 0
Intracranial haemorrhage 3 (100) 0
Subdural empyema 2 (66.7) 1 (33.3)
VP = ventriculoperitoneal.
 
Figure 1. Rates of nosocomial infections associated to the length of stay (prospective study). 
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Fig. 1. Rates of nosocomial infection in relation to length of stay.
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of Pseudomonas aeruginosa were susceptible to the commonly 
used antipseudomonal agents (cephalosporins, aminoglycosides and 
carba penems) (Table 3).
Discussion
Despite all efforts proposed by infection prevention and control 
guidelines to control nosocomial infections through improvements 
in operating rooms, ventilation, sterilisation methods, barriers and 
better surgical techniques, complete elimination of nosocomial 
infections in neurosurgical patients remains a challenging goal, and 
these infections are still one of the most important causes of mortality 
in hospitalised patients.[8]
Rates of nosocomial infections in neurosurgical patients
The overall incidence of nosocomial infection after neurosurgical 
operations in the present study was 7.5% based on clinical suspicion 
and 4.2% based on microbiological confirmation. Bellusse et al.[9] 
conducted a study on infections following neurosurgical procedures 
in a Brazilian tertiary hospital and found a 7.7% incidence rate of 
nosocomial infection. A study by Buang and Haspani[10] had similar 
results, with a 7.7% rate of nosocomial infections in Kuala Lumpur 
Hospital, Malaysia.
Analysis of types of postoperative infections seen in the present 
study revealed higher rates of SSIs compared with CNSIs (VP 
shunt infection and meningitis). Similar findings were observed by 
McClelland and Hall[11] in a study of patients in a tertiary hospital at 
the University of Minnesota (Minneapolis).
Of the patients who developed nosocomial infection in the 
present study, 69.3% were male and 30.7% were female. These 
figures correspond with those reported by Buang and Haspani[10] 
(69.5% male and 30.5% female). Other studies also show that 
males have a higher predisposition to nosocomial infections than 
females. [12] This increased risk may be because males of middle 
age are more likely than females to engage in risk behaviours such 
as drinking excessively, driving while drunk, getting involved 
in physical fights and other risky practices that render them 
susceptible to accidents. Our findings show that men with such a 
lifestyle tend to be unmarried, to live alone, not to be well educated, 
and to be unemployed.
Factors associated with nosocomial infections in 
neurosurgical patients
The present study found that a variety of risk factors were associated 
with neurosurgical infections. The main risk factors were surgical 
procedure (craniotomy), primary diagnosis (traumatic brain injury 
and brain abscess), length of hospital stay (>30 days) and patient age 
(≥35 years).
We found that craniotomy was a risk factor associated with SSI 
rather than VP shunt, and that patients who underwent craniotomy 
were more likely to develop SSI than those with VP shunt operations 
(indicated for hydrocephalus). Kassam et al.[13] in their study in Israel 
reported that the presence of a CSF leak and subsequent operation 
were risk factors for CNSI (mainly meningitis), while emergency 
surgery, clean-contaminated and dirty surgery, operative time 
>4  hours, and recent neurosurgery were found to be independent 
predictive risk factors for SSI.[9] Blomstedt[14] found that postoperative 
CSF leak was the only highly significant risk factor for SSI. Other 
studies have shown that longer duration of surgery increased the 
incidence of SSI.[15]
Govender et al.[16] stated that although development of effective CSF 
shunts represented a landmark achievement in neurosurgery, once the 
shunt is inserted, the patient is susceptible to a whole new disease entity 
together with its potential complications. It has also been postulated 
that the CSF shunt apparatus itself diminishes the host’s defences at 
the site of implantation and increases the likelihood that an inoculum 
of bacteria will progress to an infection.[7] In the present study, 83.3% 
Table 3. Frequency of isolation and antibiotic resistance of micro-organisms isolated from 71 culture-positive patients
Micro-organisms isolated Isolates, n (% of total isolates)
Resistant isolates, n (% of total  
isolates of a particular organism)
Gram-positive bacteria
Staphylococcus aureus* 14 (19.7) 6 (42.9)
Enterococcus faecalis† 8 (11.3) 3 (37.5)
S. epidermidis‡ 7 (9.9) 4 (57.1)
Streptococcus milleri§ 2 (2.8) 0
Streptococcus spp.§ 2 (2.8) 0
Gram-negative bacteria
Klebsiella pneumoniae¶ 9 (12.7) 4 (44.4)
Acinetobacter baumannii¶ 6 (8.5) 4 (66.7)
Escherichia coli¶ 6 (8.5) 2 (33.3)
Proteus mirabilis¶ 6 (8.5) 2 (33.3)
Enterobacter cloacae¶ 3 (4.2) 2 (66.7)
Pseudomonas aeruginosa‖ 2 (2.8) 0
Others** 6 (8.5) 0
MRSA = methicillin-resistant S. aureus; ESBL = extended-spectrum beta-lactamase.
*Isolates of S. aureus considered resistant were MRSA, and all were susceptible to vancomycin. All 14 S. aureus isolates were resistant to benzylpenicillin, while 8 non-MRSA isolates were 
susceptible to erythromycin and clindamycin.
†Of 8 isolates of enterococci, 3 were vancomycin resistant and also displayed high-level gentamicin resistance. The remaining isolates were all susceptible to ampicillin and benzylpenicillin.
‡Isolates of S. epidermidis considered resistant were those that tested resistant to methicillin; all isolates were susceptible to vancomycin but resistant to benzylpenicillin, erythromycin and 
clindamycin.
§All isolates of streptococci (either S. milleri or Streptococcus spp.) were susceptible to benzylpenicillin, ampicillin, erythromycin, clindamycin and vancomycin.
¶All Gram-negative isolates considered resistant were ESBL producers, and all were resistant to third-generation cephalosporins (ceftriaxone, cefotaxime and ceftazidime) and gentamicin, but 
all these ESBL-producing isolates were susceptible to carbapenems (imipenem, meropenem and ertapenem), piperacillin-tazobactam and amikacin. All ESBL-producing K. pneumoniae and E. 
cloacae were also resistant to ciprofloxacin.
‖All isolates of P. aeruginosa were susceptible to the commonly used antipseudomonal agents (cephalosporins, aminoglycosides and carbapenems).
**This group comprised K. oxytoca, H. influenzae, Citrobacter braakii and Serratia liquefaciens. No resistance was observed.
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of patients with VP shunt infection were aged <2 years. Similar results 
were found in a study by Hasanain et al.,[17] which showed that VP 
shunt failure was very common in infants, and that the most common 
cause of VP shunt failure in children <2 years was shunt infection.
Many studies have described specific evidence reported from 
the literature suggesting that the risk of infection increases when 
extraventricular devices (EVDs) such as VP shunts are retained for 
>5 days[18] and >10 days.[19] The present study showed that length 
of hospital stay was a risk factor for both SSI and CNSI, with mean 
(standard deviation) length of stay being 39.29 (3.60) days (median 33 
days). Korinek et al.[20] found that the mean time between surgery and 
the onset of SSI was 18 (25) days, while Buang and Haspani[10] found it 
to be 11.8 (22.8) days (median 10 days).[10] Liu et al.[21] suggested that 
shorter antimicrobial prophylaxis may increase post-neurosurgical 
infection. Another study reported that long duration of use of the 
drainage tube was likely to be an important factor causing postoperative 
central nervous system infection.[22] Other factors considered in the 
present study were gender, age, duration of urinary and endotracheal 
catheterisation, ventilator-associated pneumonia, and presence of an 
intraventricular drain. Except for age (≥35 years), none of these factors 
showed significant associations with either SSI or CNSI and they were 
therefore not considered as risk factors.
Antimicrobial susceptibility profiles among the  
culture-positive isolates
Among the Gram-positive bacteria, the most predominant virulent 
organism in our study was S. aureus, followed by S. epidermidis. 
Buang and Haspani[10] also reported virulence of S. aureus, as well 
as MRSA, which were the most common pathogens causing neuro-
surgical infections. Other studies such as those by Negi et al.[23] 
and Whitby et al.[24] found that Gram-positive cocci were the main 
causative organisms responsible for surgical site infections among 
neurosurgical patients.
Forty-three percent of S. aureus isolated in this study were resis-
tant to cloxacillin (MRSA), the first-line drug used in the manage-
ment of staphylococcal infections in our setting. However, all tested 
MRSA isolates from our study were susceptible to vancomycin. 
Methicillin resistance in S. aureus is mediated by the mecA gene, 
which encodes for a novel penicillin-binding protein 2a (PBP-2a).[25] 
In MRSA, exposure to methicillin inactivates the four high binding 
affinity PBPs normally present. PBP-2a, which displays a low affinity 
for methicillin, takes over the functions of these PBPs, permitting the 
cell to grow.[26] Vancomycin remains the drug of choice for treatment 
of infection caused by MRSA, although it is thought to be intrinsically 
less active than the antistaphylococcal penicillin.[26]
S. epidermidis, commonly considered to be a harmless inhabitant 
of the human skin and mucous surfaces, is becoming one of the 
main causes of healthcare-acquired infections. In general terms, 
infections by S. epidermidis are usually characterised by the formation 
of biofilms (an aggregate of microbes that does not require many 
nutrients to survive with a distinct architecture), which frequently 
develop and grow on implants used in the hospital setting. The ability 
to form biofilms on plastic devices by producing an extracellular 
material known as polysaccharide intercellular adhesion, which is 
made up of sulphated polysaccharides, is a major virulence factor for 
S. epidermidis. The formed biofilm decreases the metabolic activity of 
bacteria. The presence of sulphated polysaccharides in combination 
with impaired diffusion of antibiotics makes it difficult for antibiotics 
to clear the infection effectively unless the device is removed.
Of the total isolates of K. pneumoniae in our study, 44.4% were 
ESBL producers but were susceptible to carbapenems, piperacillin-
tazobactam and amikacin. ESBLs are β-lactamases capable of 
making bacteria resistant to penicillin, the first-, second- and third- 
generation cephalosporins, and aztreonam (but not the cephamycins 
or carpenems) by hydrolysing these antibiotics.[27] Such ESBLs may 
develop when antibiotics are taken for longer than necessary or when 
they are not needed.[27] Apart from K. pneumoniae, ESBLs in our 
study were also identified in A. baumannii and E. cloacae. All isolates 
of P. aeruginosa, however, were susceptible to the commonly used 
antipseudomonal agents. Others have reported similar susceptibilities 
to those in our study.[28] Moodley et al.[29] stated that the majority of 
A.  baumannii isolated in their study were multidrug-resistant, 
retaining susceptibility only to tobramycin and colistin. A study by 
Karlowsky et al.[30] demonstrated that >90% of A. baumannii isolates 
tested were susceptible to imipenem and meropenem.[28]
The increased resistance of A. baumannii to numerous antimicrobial 
agents is notable and has prompted its classification as a high-
priority pathogen by the Antimicrobial Availability Task Force of the 
Infectious Diseases Society of America (as reported by Moodley et 
al.[29]). Jocum[31] and Harbath et al.[32] both reported that prolonged 
antibiotic prophylaxis was correlated with an increased risk of 
acquired antibiotic resistance. Possible other reasons for increased 
resistance of A. baumannii include excessive use of antimicrobials for 
acutely ill and complex patients in hospitals, diagnostic uncertainty, 
pressure to keep length of stay short, and prescription of antibiotics 
by inexperienced doctors, e.g. in teaching hospitals.[29]
In a recent international survey of neurosurgeons and critical 
care and infectious disease specialists, 56.3% of neurosurgeons used 
prophylaxis as long as the EVD was in place, while only 11.5% of 
infectious disease specialists were in favour of doing so.[33]
The potential for survival of a microbe lies in its ability to change. 
Microbes are able to reproduce much faster than human cells. 
Bacterial cells replicate every 15 minutes, and each time a bacterium 
divides, there is a chance for error. A random change in the genetic 
makeup of a cell becomes a permanent inherited characteristic.[26] 
Use of antibiotics creates a situation in which the fittest microbes 
survive.
Study limitations
One of the key limitations of this study was identification of risk 
factors by using patients clinically suspected to have postoperative 
infections who were found to be culture-negative (microbiologically 
not confirmed) as a control group (as opposed to patients who were 
microbiologically confirmed). This is because patients who were 
clinically suspected were not tested for the presence of anaerobic 
bacteria, fungi and other fastidious micro-organisms, as this was 
beyond the scope of this study.
Recommendations
Findings from this study support the following recommendations: 
• Appropriate use of antimicrobial agents for prophylaxis and 
treatment. Since half of the isolated S. aureus and S. epidermidis, 
the prevalent Gram-positive bacteria, were resistant to first-line 
cloxacillin, and half of the commonly isolated Gram-negative 
bacteria were ESBL producers, we recommend that doctors should 
consider covering for MRSA and ESBL-producing organisms in 
any empirical treatment prescribed.
• Owing to increasing rates of multidrug-resistant organisms in 
neurosurgery, appropriate clinical samples must be collected prior 
to empirical antibiotic initiation and sent to the microbiology 
laboratory without any delay. Once laboratory results are obtained, 
empirical treatment must be corrected.
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• There is an urgent need to strengthen infection prevention and 
control activities in the ward and in theatre.
• Finally, surveillance of nosocomial infections and antimicrobial 
susceptibility testing must be performed regularly to inform 
treatment and quality improvement mechanisms.
Conclusions
Nosocomial infections remain important adverse events in the 
Department of Neurosurgery at NMAH. The overall incidence of 
microbiologically confirmed nosocomial infections was 4.2%, despite 
the high rate of culture-negative results. This figure may be an 
underestimation of the current situation considering that the present 
study did not take into account cultures of anaerobic bacteria, fungi 
and other fastidious micro-organisms.
To minimise post-surgical infections, a combination of preventive 
practices should be used. These measures include a preoperative bath, 
appropriate antiseptic agents (chlorhexidine or povidone-iodine) 
for skin preparation preoperatively, and use of appropriate wound 
dressings postoperatively.
The increasing level of antimicrobial resistance in both Gram-
positive (MRSA and emerging coagulase-negative staphylococci) 
and Gram-negative (ESBL-positive K. pneumoniae and emerging 
multidrug-resistant Acinetobacter species) bacteria in neurosurgery is 
grounds for grave concern and requires urgent attention. Appropriate 
use of antimicrobial agents for both prophylactic and therapeutic 
administration remains the first step towards overcoming the 
challenge of multidrug-resistant organisms.
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